Alexandre Gaymard
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 10
- SARS-CoV-2 detection and testing 9
- Viral gastroenteritis research and epidemiology 5
- COVID-19 Clinical Research Studies 4
- Epidemiology top 10%
- Respiratory viral infections research 15
- Influenza Virus Research Studies 10
- Pneumonia and Respiratory Infections 2
- Modeling and Simulation top 10%
- Animal Science and Zoology top 10%
-
- Viral Infections and Immunology Research 2
- Co-authors
- Bruno LinaÉmilie FrobertVanessa EscuretFlorence MorfinNolwenn BriandLaurence JossetGrégory DestrasAntonin Bal
- Journals
- Emerging infectious diseases (1 paper)Journal of Antimicrobial Chemotherapy (3 papers)Clinical Microbiology and Infection (2 papers)
- Partner nations
- FranceUnited KingdomBelgium
In The Last Decade
Alexandre Gaymard
23 papers receiving 726 citations
Peers
Comparison fields: 5 of 84
- Infectious Diseases 492
- Epidemiology 273
- Modeling and Simulation 33
- Virology 25
- Animal Science and Zoology 47
Countries citing papers authored by Alexandre Gaymard
This map shows the geographic impact of Alexandre Gaymard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandre Gaymard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandre Gaymard more than expected).
Fields of papers citing papers by Alexandre Gaymard
This network shows the impact of papers produced by Alexandre Gaymard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandre Gaymard. The network helps show where Alexandre Gaymard may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alexandre Gaymard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2022 | 23 | |
| 6 | 2022 | 10 | |
| 7 | 2021 | 0 | |
| 8 | 2021 | 10 | |
| 9 | 2020 | 141 | |
| 10 | 2020 | 48 | |
| 11 | 2019 | 3 | |
| 12 | 2019 | 15 | |
| 13 | 2018 | 3 | |
| 14 | 2018 | 6 | |
| 15 | 2017 | 1 | |
| 16 | 2017 | 15 | |
| 17 | 2016 | 116 | |
| 18 | 2016 | 6 | |
| 19 | 2016 | 19 | |
| 20 | 2016 | 1 |
About Alexandre Gaymard
Alexandre Gaymard is a scholar working on Infectious Diseases, Epidemiology and Endocrinology, having authored 30 papers that have together received 738 indexed citations. Recurring topics across this work include Respiratory viral infections research (15 papers), SARS-CoV-2 and COVID-19 Research (10 papers), Influenza Virus Research Studies (10 papers), SARS-CoV-2 detection and testing (9 papers), Viral gastroenteritis research and epidemiology (5 papers), COVID-19 Clinical Research Studies (4 papers), Pneumonia and Respiratory Infections (2 papers) and Viral Infections and Immunology Research (2 papers). The work is most often cited by research in Infectious Diseases (492 citations), Epidemiology (273 citations) and Modeling and Simulation (33 citations). Alexandre Gaymard has collaborated with scholars based in France, United Kingdom and Belgium. Frequent co-authors include Bruno Lina, Émilie Frobert, Vanessa Escuret, Florence Morfin, Nolwenn Briand, Laurence Josset, Grégory Destras, Antonin Bal, Martine Valette and Geneviève Billaud. Their work appears in journals such as Emerging infectious diseases, Journal of Antimicrobial Chemotherapy and Clinical Microbiology and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.